Cargando…
Missing lnc(RNAs) in Alzheimer’s Disease?
With the ongoing demographic shift towards increasingly elderly populations, it is estimated that approximately 150 million people will live with Alzheimer’s disease (AD) by 2050. By then, AD will be one of the most burdensome diseases of this and potentially next centuries. Although its exact etiol...
Autores principales: | Policarpo, Rafaela, d’Ydewalle, Constantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774680/ https://www.ncbi.nlm.nih.gov/pubmed/35052379 http://dx.doi.org/10.3390/genes13010039 |
Ejemplares similares
-
From Junk to Function: LncRNAs in CNS Health and Disease
por: Policarpo, Rafaela, et al.
Publicado: (2021) -
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
por: d’Ydewalle, Constantin, et al.
Publicado: (2015) -
Insights into lncRNAs in Alzheimer’s disease mechanisms
por: Li, Dingfeng, et al.
Publicado: (2020) -
LncRNAs as the Regulators of Brain Function and Therapeutic Targets for Alzheimer’s Disease
por: Liu, Yuqing, et al.
Publicado: (2022) -
New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer’s Disease
por: Hao, Yitong, et al.
Publicado: (2022)